Background. Individuals C80 years of age represent an increasing proportion of colon cancer diagnoses. Selecting these patients for elective surgery is challenging because of diminished overall health, functional decline, and limited data to guide decisions. The objective was to identify overall health measures that are predictive of poor survival after elective surgery in these oldest-old colon cancer patients. Methods. Medicare beneficiaries C80 years who underwent elective colectomy for stage I-III colon cancer from 1992-2005 were identified from the Surveillance, Epidemiology and End Results(SEER)-Medicare database. Kaplan-Meier survival analysis determined 90-day and 1-year overall survival. Multivariable logistic regression assessed factors associated with short-term postoperative survival. Results. Overall survival for the 12,979 oldest-old patients undergoing elective colectomy for colon cancer was 93.4 and 85.7 %, at 90 days and 1 year. Older age, male gender, frailty, increased hospitalizations in prior year, and dementia were most strongly associated with decreased survival. In addition, AJCC stage III (vs stage I) disease and widowed (vs married) were highly associated with decreased survival at 1 year. Although only 4.4 % of patients were considered frail, this had the strongest association with mortality, with an odds ratio of 8.4 (95 % confidence interval, 6.4-11.1).
The United States population is aging, with much of the growth occurring in individuals C80 years of age. 1 These changes in the nation's demographics have had a significant impact on cancer care. This is especially true for colon cancer, where the incident rate increases with age, to a peak of more than 350 cases/100,000 individuals C80 years of age.
2 Surgical decision-making for these ''oldest-old'' patients is unique. Limited evidence exists to inform colon cancer treatment decisions in the oldest-old adults, as this population has been underrepresented in cancer clinical trials and excluded from clinical practice guidelines. 3 Additionally, many oldest-old adults are at increased perioperative risk because of diminished overall health status and functional decline. Balancing these factors makes oncologic treatment decision-making for these patients challenging.
Overall health status and functional decline can be measured through a number of distinct, but related, domains, and a growing body of literature suggests that these domains are highly associated with surgical outcomes in elderly patients. 4 Assessable domains include overall healthcare utilization, comorbidity, disability (difficulty or dependence in 1 or more activities of daily living), and frailty. Frailty in particular has been associated with a number of surgical postoperative outcomes, including increased hospital and postdischarge costs, postoperative length of stay, complications, likelihood of requiring institutionalization after discharge, and 6-month mortality. [5] [6] [7] [8] [9] [10] [11] Frailty is characterized by decreased physiologic reserve and resistance to stressors, which occurs as a result of physiologic multisystem decline. 12 Importantly, by this definition, patients may be frail without having a life-threatening illness. 13 Surgical resection is the primary treatment for colon cancer. For patients C80 years of age, a significant percentage of surgeries (20-45 %) occur during an urgent or emergent admission and are associated with increased complications and decreased survival. [14] [15] [16] [17] Despite the increased perioperative risk associated with surgery under urgent or emergent conditions, these patients represent less of a decision-making challenge for surgeons, as the acuity and severity of the presenting symptoms often alter the risk-benefit ratio for even the highest-risk patient. More challenging is that subset of patients who present electively for consideration of colectomy for cancer. Although most of these patients do well after surgery, clinical practice suggests that there is a subset of older patients who do extremely poorly after an elective colectomy. Identification of these patients preoperatively would enhance the quality of informed consent and aid in surgical decision-making. Therefore, we sought to identify preoperatively recognizable measures of overall health that are predictive of poor short-term survival after elective surgery in the oldest-old colon cancer patients.
METHODS
This study was reviewed by the University of Wisconsin Institutional Review Board and granted a waiver of consent.
Data Source
The linked Surveillance, Epidemiology and End Results (SEER)-Medicare database was used to identify patients undergoing colon cancer surgery from 1992 to 2005. The SEER-Medicare data resource has been previously described by our group and others and is an established resource for studying longitudinal cancer in elderly patients.
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Patient Selection
Our primary cohort of interest was Medicare-enrolled patients aged 80 years and older diagnosed with stage I-III primary colon adenocarcinoma within a SEER region between 1992 and 2005. However, data for patients 65-79 years of age was also examined to provide a comparative group against which outcomes for the oldest-old colon cancer patients could be grounded. SEER anatomic site (18.0-18.9, 19.9) , and histology (8140-8417, 8210-11, 8220-21, 8260-63, 8480-81, 8490) codes were used to identify colon cancer patients. Patients were included in the study if they underwent colectomy (ICD-9 procedure codes: 45.7X and 45.8X) during an elective hospital admission (defined using admission type variable within the Medicare Provider Analysis and Review File). Patients undergoing surgery more than 90 days after diagnosis were excluded, as these operations were less likely to be of curative intent. Continuous enrollment in Medicare Part A and B was required for the 3 years preceding diagnosis through the 3 years following discharge, death, or December 31, 2005 (whichever came first) to allow ascertainment of comorbidities and survival. Patients were excluded if they were enrolled in a Health Maintenance Organization during the same time period. Patients were also excluded if they were diagnosed with another malignancy 1 year before or after the date of colon cancer diagnosis, or if their first diagnosis of colon cancer was made after death (i.e., on autopsy or death certificate). From an initial cohort of 42,873 stage I-III colon cancer patients C80 years of age, the following patients were sequentially excluded: stage IV disease or unknown stage (n = 11,122), discontinuous Medicare Part A and Part B coverage (n = 1012), another cancer within 1 year of colon cancer diagnosis (n = 2968), and surgery during a nonelective admission (n = 14,792). The final sample size was 12,979 patients.
Outcome Variables
The primary outcome measures for this study was 90-day overall survival. This was defined using dates of death recorded in the SEER Patient Entitlement and Diagnosis Summary File (PEDSF) according to Social Security Administration data. Additionally, we examined 1-year overall survival, length of stay, discharge destination, 30-day readmission rates (readmission to any acute care hospital), and receipt of adjuvant chemotherapy (defined as any claim for chemotherapy within 9 months of surgery [ICD-9 V58.1, V66.2, V67.2, E9331, 99.25; CPT 96400-96599; Health Care Common Procedure Coding System codes Q0083-Q0085, E0781, C8953-5, S9329-31, G0355-63; J0640, J8520, J8521, Q0177, J8510, J8530-J8999, J9000-J9999; Revenue center codes 0331, 0332, 0335). 19, 23, 24 Patient-Related Variables Basic demographics, including date of birth, gender, race/ethnicity, and marital status, were obtained from SEER data. Socioeconomic status was assessed using census tract median level of household income and median level of education. Geographic region was represented by SEER registry. Tumor stage was assessed using American Joint Committee on Cancer (AJCC) staging.
Patients' overall health was assessed by a number of means. Health care utilization was assessed by recording the number of emergency room and hospital admissions in the year prior to diagnosis. Specific comorbidities were identified, as described by Elixhauser et al. 25 Dementia was identified using a separate, validated algorithm given the importance of dementia in treatment-decision-making for older adults (using ICD-9 codes 331.0-331. 26 Disability was indirectly assessed by examining home oxygen use and mobility. Home oxygen was recorded if patients had 2 codes related to home oxygen use (DME A7017) in the 3 years prior to diagnosis. Mobility was assessed by examining claims for ambulatory-assist devices in the 3 years prior to diagnosis (assessment for device: 97755, 97542; cane: E0100, E0105; crutch: E0110-E0017; walker: E0130, E0135, E0140-E0141, E0143-E0144, E0147-E0149; wheelchair: K0001-K0007, E0983, E0984, E1210-E1213, E2368-E2370, K0010-K0012, K0014, K0800-K0899). Patient frailty was assessed as defined by the John Hopkins' Adjusted Clinical Groups (ACG) case-mix system. This validated measure of frailty was developed to be used specifically on administrative data and assesses frailty by the presence of 11 conditions (e.g., difficulty walking, weight loss, frequent falls, malnutrition, impaired vision, decubitus ulcer, incontinence, etc.). 27 Dementia is 1 of the 11 conditions included in the ACG definition of frailty; however, it was excluded from the frailty definition in this study as it was being incorporated into the model as a unique variable (described previously). Patients having ICD-9 diagnosis codes for any of these conditions were considered to be frail; of the ''frail'' patients, 80 % were considered to be frail based on a single criteria. The most common single codes were difficulty walking (56 %), weight loss (24 %), and decubitus ulcers (12 %); the remaining codes occurred most frequently in combination.
Analysis
Descriptive statistics of patient characteristics were generated, and differences between the cohort C80 years of age and \80 years of age were compared using v 2 tests and 2-sample t tests. Short-term outcomes (length of stay, discharge destination, and hospital readmission rates) were summarized. v 2 tests and 2-sample t tests were used as appropriate to compare outcomes between patients \80 and C80 years of age. Kaplan-Meier survival analysis was used to obtain 90-day and 1-year overall survival estimates, and log-rank tests were used to compare survival outcomes between patients \80 and C80 years of age. Separate logistic regression models were used to evaluate 90-day and 1-year mortality (binary yes/no variable). These multivariable logistic models adjusted for a variety of factors related to patient demographics, tumor, and overall health status.
RESULTS
Patient characteristics of the 12,979 eligible patients C80 years of age are presented in Table 1 . The mean age of the oldest-old cohort was 84.4 years, and the majority were female (61.4 %), white (90.1 %), and unmarried (56.3 %). Localized (node-negative) colon cancer was present in 72.7 % of our cohort. Characteristics of the 19,451 patients \80 years of age are included for comparison, and as would be expected, significant differences existed.
The oldest-old patients undergoing elective colectomy were relatively healthy, with few hospital admissions in the prior year (mean, 1.44), and few patients requiring home oxygen (2.3 %) or a wheelchair (3.7 %). The most common comorbidities included hypertension (76.3 %), congestive heart failure (35.8 %), peripheral vascular disease (29.6 %), chronic pulmonary disease (25.6 %), and diabetes (23.5 %). Few patients met criteria for dementia (.9 %) or frailty (4.4 %).
Short-term outcomes for our oldest-old patient cohort were generally good compared with that of ''younger'' patients (Table 2 ). Median length of stay was 9 (2-165) days. The majority of patients were discharged home, with 22.1 % being discharged to a skilled nursing facility. Readmission within 30 days of discharge occurred for 10.9 % of patients. Only 14 % of patients C80 years of age received chemotherapy.
The 90-day and 1-year overall survival for our patient population was 93.4 and 85.7 %, respectively (Fig. 1) , compared with 97.6 and 93.5 % for ''younger'' patients. Of those oldest-old patients who died by 90 days after surgery, only 41 % were as a result of their colon cancer. Factors associated with poorer 90-day and 1-year overall survival are presented in Table 3 . At both time points, older age, male gender, frailty, increased hospitalizations in the prior year, and dementia were most strongly associated with poorer survival. In general, specific comorbidities were not associated with 90-day or 1-year survival. In addition, AJCC stage III disease and being widowed were highly associated with poorer survival at 1 year. Overall survival by AJCC stage was 90.0 % for stage I, 87. (Fig. 2) . 
DISCUSSION
Most oldest-old colon cancer patients do well after elective surgery, with 85.7 % alive at 1 year. However, a significant proportion of patients (6.6 %) died by 90 days after surgery, and the majority of these deaths were unrelated to their colon cancer diagnosis. The ability to identify those patients at increased risk of early postoperative mortality after elective surgery has a number of significant implications. This information would improve the informed consent process by better aligning patient expectations with anticipated outcomes, specifically the risk of early postoperative mortality. Our prior research has demonstrated that the majority of colon cancer patients C80 years of age (including those not selected for surgical resection of their cancer) die of causes unrelated to their colon cancer. 28 Therefore, the ability to prospectively identify a cohort of patients being considered for elective surgery who are at risk for especially poor short-term survival may facilitate open conversations about the risk of death and the option of nonoperative therapeutic alternatives for management of the colon cancer. Finally, preoperative identification of at-risk patients could guide preoperative referral to a geriatrician for optimization prior to surgery.
After controlling for patient demographics, cancer stage, and other health factors, patient frailty was the strongest predictor of poor short-term postoperative survival. Of the deaths during the first 90 days after surgery, 27 % occurred in patients identified as frail. This raises the possibility that frailty could be used as a marker to identify patients at increased risk of early postoperative mortality.
Frailty has been measured in the clinical setting through a variety of means. Two commonly used approaches to assess frailty have been described. The first defines frailty based on a ''classic phenotype'' comprising specific factors, including weight loss, weakness, poor endurance, slowness, and low activity. 12 The second method depends less on which specific factors are present, but focuses instead on the absolute number of accumulated factors to determine if a patient is frail. 13 These 2 approaches have been captured through a variety of scoring systems requiring either direct patient assessment (such as measurement of grip strength, time required to walk 15 feet, etc.), brief patient surveys, and evaluations based on more comprehensive geriatric assessments. 6, 10, 12, [29] [30] [31] Although each measure has been found to be predictive of frailty and outcomes, a major limitation to their utility is surgeons' ability and willingness to adopt them into everyday clinical practice.
Surgeons perform a thorough assessment of patients overall well-being at the time of a preoperative evaluation, relying on assessment of comorbidity through review of the medical records and conversations with primary care doctors. However, although surgeon awareness of the importance of frailty is increasing, the lack of an efficient means of assessing frailty in the clinical setting means that surgeons rely on their clinical judgment to provide an overall gestalt of their patients' wellness and ability to undergo surgery, rather than a formal assessment of frailty. In our study, the most common frailty criteria included difficulty walking, weight loss, and frequent falls. Because these frailty factors could exist in the absence of documented comorbidity or disability, this important clinical factor may be overlooked in the standard surgeon preoperative assessment.
By using the Hopkins ACG case-mix definition of frailty, we were able to identify frail patients at increased risk of early mortality through billing claims. The ability to Additionally adjusted for SEER registry, urban/rural residence, census track income and proportion of non high-school graduates, and year of diagnosis AJCC American Joint Committee on Cancer, ER emergency room identify frail patients using administrative data makes it likely that we would be able to identify these same patients prospectively through an electronic medical record. We would theoretically be able to create ''flags'' in the electronic medical record to alert surgeons that a particular patient is frail and at increased risk of early mortality. The ease of identifying patients through the electronic medical record would overcome many of the implementation challenges other assessments of frailty have had when being adopted into clinical practice and would provide surgeons with an efficient means of identifying these especially high-risk patients. Several limitations exist to our study. First, our ability to assess patients' overall health was limited to what we could abstract from the Medicare claims data. Although we were able to abstract specific comorbidities, we found little relationship between the presence of specific comorbidities and overall survival, even for those comorbidities which would be hypothesized to be associated with poor outcomes (such as congestive heart failure or complicated diabetes). This may reflect the fact that although the presence of the comorbidity was captured in the billing record, there is no information available regarding the severity of that comorbidity. This is especially relevant for those patients C80 years of age, many of whom will have accumulated a significant list of comorbidities; however, the very fact that they have lived to become octogenarians and nonagenarians implies that the severity of those comorbidities (or at least their impact on longevity) is likely low. Additionally, we were unable to directly assess disability (a factor known to be related to postoperative outcomes), relying instead on indirect measures such as claims for home oxygen and ambulatory assist devices. 32 Next, using billing data, we classified 4.4 % of our oldest-old adults as frail, a significantly lower rate than that reported by Fried et al. using prospectively collected data for patients [85 years of age (13 %). 12 In order to be considered frail using the definition validated by the ACG case-mix system, an appropriate contributing diagnosis needs to be documented, most likely by the patients' primary care doctor or geriatrician. It is likely that the conditions that lead to a patient being considered frail are only documented in those oldest-old adults where the condition is having a significantly negative impact on their overall well-being; as a result, those patients considered to be frail in our study likely reflect only the most severely impaired individuals. We are, therefore, likely underestimating the number of frail adults and cannot comment on the relationship between lesser degrees of frailty and outcome. Finally, we were unable to assess the relationship between our measure of frailty and relevant outcomes other than survival (such as quality of life and maintaining functional independence). 33 However, our study has a number of strengths. This is the first study to demonstrate that frailty, which is so strongly linked to early mortality, can be identified through billing codes. Although this measure likely underestimates the number of frail adults, those patients identified as being frail had remarkably poor short-term survival. This measure of frailty has predictive value in identifying those patients at greatest risk of early mortality and would contribute critical clinical information to preoperative discussions. This has the potential to significantly improve the decision-making process for surgeons and their oldestold patients.
In conclusion, in this analysis of the SEER-Medicare database, we identified frailty as the strongest predictor of a poor short-term survival after elective colon cancer surgery in patients C80 years of age. The ability to identify frailty with administrative data suggests that it should be possible to create ''frailty flags'' in the electronic medical record, thereby identifying individuals who are at highest risk for poor postoperative survival. The measure of frailty that we used is highly predictive and could be incorporated into surgical clinical practice via the electronic medical record. Given the demonstrated resistance of physicians to the incorporation of decision-support tools in clinical practice, the potential for seamless integration of high-value indicators of risk through the electronic medical record has important implications for streamlining surgeon practice and supporting decision making, and this is a promising direction for future research. [34] [35] [36] ACKNOWLEDGMENT This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the 
